BLOODGENETICS signed a collaboration agreement with CIEMAT and Dr José Carlos Segovia Sanz group for future development of Gene Therapy in Congenital Dyserythropoietic Anemia in Neotec2019 application context. Thanks to patient association ADISCON support!
BLOODGENETICS signed a collaboration agreement with CIEMAT and Dr José Carlos Segovia Sanz group for future development of Gene Therapy in Congenital Dyserythropoietic Anemia in Neotec2019 application context. Thanks to patient association ADISCON support!
Autor: Santiago Perez
http://bloodgenetics.comDeja una respuesta Cancelar la respuesta
BLOODGENETICS signed a collaboration agreement with CIEMAT and Dr José Carlos Segovia Sanz group for future development of Gene Therapy in Congenital Dyserythropoietic Anemia in Neotec2019 application context. Thanks to patient association ADISCON support!